CUTTER LAB has a total of 499 patent applications. Its first patent ever was published in 1932. It filed its patents most often in United States, Canada and United Kingdom. Its main competitors in its focus markets medical technology, machines and pharmaceuticals are APAMED ANST, FUNDATECH SA and ZERBINI E J FUNDACAO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 215 | |
#2 | Canada | 65 | |
#3 | United Kingdom | 34 | |
#4 | Germany | 33 | |
#5 | Japan | 24 | |
#6 | France | 23 | |
#7 | Australia | 17 | |
#8 | Spain | 17 | |
#9 | Switzerland | 11 | |
#10 | Sweden | 11 | |
#11 | EPO (European Patent Office) | 7 | |
#12 | Brazil | 6 | |
#13 | Israel | 5 | |
#14 | Belgium | 4 | |
#15 | Netherlands | 4 | |
#16 | Argentina | 3 | |
#17 | New Zealand | 3 | |
#18 | South Africa | 3 | |
#19 | Austria | 2 | |
#20 | Italy | 2 | |
#21 | Republic of Korea | 2 | |
#22 | Norway | 2 | |
#23 | Denmark | 1 | |
#24 | Greece | 1 | |
#25 | Mexico | 1 | |
#26 | Portugal | 1 | |
#27 | Romania | 1 | |
#28 | Yugoslavia (Serbia and Montenegro) | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Machines | |
#3 | Pharmaceuticals | |
#4 | Organic fine chemistry | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Syringes | |
#3 | Unspecified technologies | |
#4 | Heterocyclic compounds | |
#5 | Implantable devices | |
#6 | Microorganisms | |
#7 | Unspecified technologies | |
#8 | Medical purpose containers | |
#9 | Acyclic or carbocyclic compounds | |
#10 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Butler William F | 27 |
#2 | Kahn Paul | 25 |
#3 | Cutter Fred A | 15 |
#4 | Lundblad John L | 14 |
#5 | Kahn P | 13 |
#6 | Faust John A | 11 |
#7 | Warner Willis L | 11 |
#8 | Beacham Robert C | 10 |
#9 | Hidalgo John | 10 |
#10 | Von Alven Raymond D | 10 |
Publication | Filing date | Title |
---|---|---|
US4499073A | Intravenously injectable immune serum globulin | |
US4447414A | Carnivore anthelmintics | |
US4440679A | Pasteurized therapeutically active protein compositions | |
US4479989A | Flexible container material | |
US4450104A | Water insoluble gel matrix containing lectin bound to antithrombin | |
US4446314A | Fractionation of heparin | |
US4412990A | Composition having enhanced opsonic activity | |
US4379087A | Method of preparing alpha-1-proteinase inhibitor | |
US4435177A | Needle assembly | |
US4455300A | Fibronectin compositions | |
US4391746A | Blood-coagulation-promoting products and methods of preparing them | |
EP0064210A1 | Oral pharmaceutical composition containing immune globulin | |
US4477432A | Oral immune globulin | |
US4446126A | Antithrombin-heparin complex and method for its production | |
US4404132A | Blood coagulation promoting product | |
US4361510A | Blood coagulation promoting product | |
US4414238A | Liquid elemental diet | |
US4416661A | Injection site for fluids | |
EP0054221A1 | Multiple blood bag system made of plastic substantially free of blood extractible plasticizers | |
US4391801A | Plasma protein fraction substantially free of acetate ions |